PI Industries Limited — Investor Meet, 12-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

PI Industries reported Q3 FY26 revenue of ₹1,375.7 Cr (down 28% YoY) and EBITDA of ₹302.7 Cr (down 41% YoY). Net Profit was ₹311.3 Cr, boosted by an exceptional ₹126 Cr income. For 9M FY26, revenue stood at ₹5,148.5 Cr (down 17% YoY), with EBITDA at ₹1,368 Cr. Management noted Q3 demand softness due to delivery schedules, farmer demand, and weather. Pharma sales for 9M grew 50% YoY. The company expects growth to pick up from Q4 FY26, driven by new products and biologicals. PI maintains a robust, debt-free balance sheet with ₹3,506.6 Cr surplus cash for strategic investments. Focus remains on margin discipline and scaling new platforms.